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ABSTRACT
ALTERED DEVELOPMEMENTAL PROGRAMMING OF THE MOUSE
MAMMARY GLAND IN FEMALE OFFSPRING FOLLOWING PERINATAL
DIETARY EXPOSURES: A SYSTEMS-BIOLOGY PERSPECTIVE
CALEB DEEN BASTIAN
November 21st, 2008
Mishaps in prenatal development can influence mammary gland development
and, ultimately, affect susceptibility to factors that cause breast cancer. This research was
based on the underlying hypothesis that maternal dietary composition during pregnancy
can alter developmental (fetal) programming of the mammary gland.We used a
computational systems-biology approach and Bayesian-based stochastic search variable
selection algorithm (SSVS) to identify differentially expressed genes and biological
themes and pathways. Postnatal growth trajectories and gene expression in the mammary
gland at 10-weeks of age in female mice were investigated following different maternal
diet exposures during prenatal-lactational-early-juvenile development. This correlated a
decrease in expression of energy pathways with a reciprocal increase in cytokine and
inflammatory-signaling pathways. These findings suggest maternal dietary fat exposure
significantly influences postnatal growth trajectories, metabolic programming, and
signaling networks in the mammary gland of female offspring. In addition, the
adipocytokine pathway may be a sensitive trigger to dietary changes and may influence
or enhance activation of an immune response, a key event in cancer development.
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1. INTRODUCTION
Over fifteen years ago, Barker and colleagues hypothesized that adverse
environmental factors in early life, particularly nutritional deficiencies, disrupt fetal
growth and development, leading to a more susceptible adult phenotype prone to
cardiovascular disease (Barker, Bull et al. 1990; Dobbing 1993; Barker 1995). After a
worldwide series of epidemiological studies, in which fetal growth restriction was
demonstrated to be correlated with chronic disease in adulthood, this hypothesis became
known as the developmental origins of health and disease (DOHAD) or Barker
hypothesis. It states that environmental factors act in early life to program the risks for
major chronic diseases, such as cardiovascular disease, stroke, hypertension, type 2
diabetes, and obesity later in life.
It is well recognized that during development, there are critical periods of
vulnerability to suboptimal conditions when developmental programming may
permanently modify disease susceptibility (Lucas 1998). Developmental programming
involves structural changes in important organs: altered cell number, imbalance in
distribution of different cell types within the organ, and altered blood supply or receptor
numbers (Armitage, Khan et al. 2004). Tissues that have been identified as targets for
programming include heart, kidney, liver, pancreas, and adipocytes (McMillen and
Robinson 2005). For the mammary gland, data on developmental programming are still
limited. Changes in maternal diet have been demonstrated to alter mammary gland
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differentiation (Hilakivi-Clarke, Stoica et al. 1998; De Assis and Hilakivi-Clarke 2006).
This might influence further development of the mammary gland and, ultimately, play an
important role in determining later risk to breast cancer through epigenetic mechanisms
(i.e. ubiquitinization, phosphorylation, chromatin methylation, histone acetylation,
sumovlation). A link between maternal nutrition in pregnancy and breast cancer risk in
adult life has been proposed but not established.
The goal of the study presented here was to identify cellular-response pathways
underlying fetal programming of the murine mammary gland by nutrition. The Barker
hypothesis has mainly focussed on the impact of maternal undernutrition. However,
maternal and postnatal nutrition are either sufficient or excessive in developed countries.
In fact, not only undernutrition, but also a disbalance of nutrition in the opposite direction
correlates with adult diseases, such as cancer. Breast cancer incidence rates are about
fourfold higher in Europe and North America than in Asia and Africa (Hortobagyi, de la
Garza Salazar et al. 2005; Parkin, Bray et al. 2005). Besides other lifestyle factors,
consumption of a Western diet, and more specifically dietary fat intake, has been
demonstrated to be a major risk factor (Kato, Tominaga et al. 1987; Mattisson, Wirfalt et
al. 2004; Binukumar and Mathew 2005). Epidemiological studies have suggested a
positive relation between dietary fat intake and breast cancer risk (Howe, Hirohata et al.
1990; Prentice and Sheppard 1990; Boyd, Stone et al. 2003), and this has also been
demonstrated in rodents. Here, we investigated the effect of different perinatal diet
exposures, using high-fat diets high in n-6 or in n-3 polyunsaturated fatty acids, on
programming of the murine mammary gland (Figure 1) by studying gene expression
profiles in relation to body weight trajectories. This thesis comprises a computational
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analysis of a recent dataset from a collaboration between the University of Louisville and
RIVM, the Netherlands.
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Figure 1. Mouse mammary tree
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2. THEORY (Singh, Rouchka et al. 2007)
2.1. Systems Biology Research Strategies
Systems biology is an interdisciplinary science that aims at system-level
understanding of biological systems (biosystems). It has been only recently, through
progress in the human genome project and advancement of newer technologies for highcontent data generation, that a system-level analysis has been enabled at the molecular
level. Grounded in the coupling of experimentation (in vivo, in vitro) with computation
(in silico), this approach has applications toward building predictive models that are
integrative, quantitative, and dynamic in nature. A general workflow paradigm is
diagrammed in Figure 2 .
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Figure 2. Workflow for inference and prediction in a systems biology paradigm
Biological attributes observed from hypothesis-driven studies on the natural system are
used to make inferences at different informational levels; this information is used to
formalize the system with mathematical models. These models are tested with simulated
and empirical data to then predict behaviors in the natural system. The process is iterated
to improve performance and accuracy (adapted with permission from Dr. Wolkenhauer).
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To integrate a biological system both top-down and bottom-up strategies must be
considered. The former starts with the system as a whole and decomposes it to smaller
modular entities, e.g., phenotypes molecules. The strength in a top-down view of birth
defects is that overall knowledge of the system can be broken down based on clinical
phenotype, independently of detailed molecular knowledge. The weakness, however, is
that not all critical components or interactions may be known at the cellular and
molecular levels. A bottom-up strategy rather starts with basic entities (genes, proteins)
and integrates them into relevant patterns and functions (pathways, networks). The
strength in this approach is that detailed molecular knowledge is available for a large
number of molecular entities, and the weakness is the limited capacity to project the
effect of perturbations in pathway models onto the cell as a whole.
Given that a cell is the basic functional unit of a tissue, an ideal modeling
framework should serve both strategies by providing a perspective that can be scalable
down to the level of individual genes and scalable up to the level of the developing
system or embryo. Fundamental epistemological issues facing systems biology were
explored by O'Malley and Dupré in their recent BioEssay article (2005). These authors
discuss two fundamental philosophies: pragmatic and theoretical. In the pragmatic
paradigm, scientists use local data to construct pathways and to structure networks based
on current knowledge. In Figure 2, for example, we represent the pragmatic school by the
vertical integration of data from signaling pathways to physiological states. Exposure to
various teratogens that give rise to a particular malformation or syndrome of
malformations can be monitored by high-content technology platforms yielding diverse
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data. This philosophy can be applied in top-down (phenotypes → molecules) or bottomup (molecules → phenotypes) mode, although in principle the genome is given the
highest causal and informational priority over other informational levels.
In the theoretical paradigm, priority is given to higher-level processes and
properties of a biosystem and the genome is deprioritized. In Figure 2, for example, the
natural system is observed by experimentalists using a traditional hypothesis-driven
scientific method to yield information on various biological attributes at different
information levels, e.g., molecular abundance profiles, gene-product association
networks, metabolic and regulatory pathways, biomarkers of cellular processes and
function, and clinical (physiological or anatomical) phenotypes. The morass of such data
require expertise in bioinformatics, statistics, and applied mathematics to make inferences
about the overall system properties and build models of the formal system that can lead to
meaningful predictions of the behavior of the system under different parameters.
In their BioEssay paper, O'Malley and Dupré (2005) raise three fundamental
questions with regard to the basic theme of integration common to both schools of
systems biologists: what is a system (structure); what biological units map onto a system
(modules); and how are modular response characteristics regulated (control) and/or
constrained by the system (logic)? A system may be defined generally as a group of
entities comprising a whole, in which each component interacts with or is related to at
least one other component functioning together to achieve the same objective.
Enumerating components of the system is important for understanding of structure of the
system, such as network topologies; however, the essence of a system resides in its
dynamics. These dynamics must be studied in quantitative terms to construct models with
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predictive capability. It would, however, be misleading to focus on system structuredynamics without paying attention to the diversity and functionality of its component
parts. In the real world, objects may be part of the system environment but not
necessarily required by the system to operate. Consider a light bulb inside a refrigerator
unit: function of the light bulb may enhance the unit's environment but it is not critical for
the unit's main function.
2.2. Scaling, Details, and Integration
Complex biological systems may be viewed from the perspective of integrated
modules whose relationships and properties are determined by function of the system as a
whole. The concept of modularity implies an assemblage of minimal functional units
(subsystems) that interact with one another to give rise to emergent properties (higher
order properties that arise from the interaction of fundamental processes in the system) of
the system. A challenge for systems biology is to define the structure of the system and
its modularity in terms of the inherent properties of a self-organizing system: energy,
control, and robustness.
Just as the discovery of the cell as the microscopic unit of life changed the way
life itself is understood, it is logical to consider the cell as the computational unit of an
embryo. Embryos are composed of diverse cells that are each made up of multiple
interacting entities or parts (e.g., genes, proteins, and metabolites). Information in
biological systems moves both up and down the scale, from molecules phenotype and
phenotype molecules (Figure 2). Data-driven abstraction in biosystems also moves up
and down in scale, from genes genome and metabolites metabonome. Whether based on
high information content or high data content, the cell provides a midlevel focal plane
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from which one can move upward or downward in scale. Because newer technologies for
live-cell imaging enables the study of single cells in action, model-building can be
anchored to the cell as a scale factor and the basic properties of a self-organizing system
(energy, control, robustness) can be applied whether the scale is multicellular or
subcellular.
Developing embryos can be abstracted as a collection of interacting autonomous
modules in which the behavior of each biomodule is controlled by an internal genetic
program that can respond to local and systemic signals. We may assume that a system
entails groups of cells that continuously interact with one another and with their local
environment. Understanding the properties of a system at a multicellular dimension thus
requires knowledge of biophysical constraints, such as composition of the extracellular
milieu, the chemical nature of signal molecules that are being exchanged between cells,
and the kinetics of chemical diffusion and receptor interaction. Similar knowledge is
needed for modeling subcellular systems, although scaling requires consideration of
signal transduction pathways that modulate gene expression.
Several resources are publicly-available that utilize a universal standard exchange
format to represent pathway-based models in general terms. To name a few: Systems
Biology Markup Language (SBML; http://www.sbml.org) is well-suited for building
programs to model biological processors as a wiring diagram; BioTapestry
(http://www.biotapestry.org) meets the informational needs for computational modeling
of developmental gene regulatory networks using the SBML workbench; CellDesigner
(http://www.CellDesigner.org) creates process diagrams that can be linked to computerreadable SBML files; and CytoScape (http://www.cytoscape.org) can be applied to
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visualizing molecular interaction networks and integrating these interactions with gene
expression profiles. These resources have broad applications for mapping connections
between entities (genes, proteins, metabolites) in a cell to visualize how specific
molecular mechanisms are linked with cellular physiology, and to build data-driven
mathematical models for the analysis and prediction of druggable-targets or
environmental-response pathways.
2.3. Comparative bioinformatics
Constructing analytical and predictive models for birth defects research is
constrained by an incomplete understanding of the fundamental parameters underlying
embryonic susceptibility, sensitivity, and vulnerability. To understand a developing organ
system from a systems biology perspective, key developmental milestones must be
parameterized in terms of system structure and dynamics, the relevant control methods,
and the overall design logic. This is predicated on the availability of high-content data
from studies in developmental biology and toxicology, coupled with the availability of
bioinformatics resources to help interpret these data.
Generally, the classification of genes that are up- and downregulated under
specific experimental conditions or disease states using microarray-based analysis
remains an essential part of this strategy. The availability of public resources for
bioinformatics studies, coupled with the acquisition of contextual data from in-house
experimentation or national data repositories, has popularized the effort to unravel
complex biological networks using a workflow such as in Figure 3.
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Figure 3. System-level workflow for empirical and computational definition of a
network.
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Newer technologies in the genomic sciences have facilitated systems biology. A
challenge is to assign quantitative values to multiple entailments (genes, proteins,
metabolites) under different biological states. Because these technologies are focused on
data generation, they emphasize scale at the expense of mechanistic understanding. This
fundamental problem requires the integration of gene expression with functional
information. Two general classification approaches have been used for this integration:
class enrichment and phenotypic enrichment. Class enrichment entails a non a priori
stratification of biological themes across a list of genes ordered on the basis of expression
difference between biological conditions. This data-driven method usually starts with
some type of multivariate statistical method that clusters the genes in each sample by
expression profile. An advantage is the ability to discover coarse biological themes
without prior knowledge of the system, under the assumption that products of
functionally related genes have similar expression profiles and hierarchical relationships.
Phenotypic enrichment on the other hand entails an a priori assessment as to whether
specified, predefined sets of genes are enriched in a list of genes ordered by expression
difference between biological conditions. An advantage here, of course, is the ability to
anchor new information with existing (prior) knowledge. In both cases, hierarchical
clustering can find simpler developmental trajectories. Most clustering approaches do not
account for the serial dependencies of time-course gene expression data. For that reason
they may have difficulty determining the optimal number of trajectories that accurately
describe time-series data. Several statistical methods have been devised to solve this
problem. The use of these methods in conjuction with network-based analysis will allow
for identification of cellular-response pathways in the considered dataset of fetal
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programming of the murine mammary gland. This approach may have sufficient
resolution to establish the hypothesis that maternal dietary fat balance during pregnancylactation has a lasting effect on mammary gland development in her daughter.
2.4. Modeling
2.4.1. Mathematics Pipeline
Toward the goal of prioritization of chemicals for screening and regulation, the
scientific research and regulatory policy enterprise requires a process model for
developmental toxicity based on a reference connectivity map similar to what was
described by Lamb et al. (2006). As mentioned earlier, part of this effort will depend on
model-building functional networks from qualitative network topologies such as directed
acyclic graphs (DAGs) of interactions based on expression data. Many methods of
adapting qualitative models to learn the continuous-time character of gene regulatory
networks have been proposed, including: discrete models that assume the network entities
can be represented in binary state (on or off); continuous-time models with pairwise and
weighted sum networks based on relationships between entity pairs; and Bayesian or
belief networks that allow model-building with hidden variables and incorporate prior
knowledge.
Discrete models in which the precise outcomes are accurately known have been
successful for modeling simpler genetic networks based on Boolean operators (gene is on
or off). Gastrulation in sea urchin, for example, is built on a computational framework of
50 or so genes affecting modules of cell fate. Boolean models generally assume only two
possible states (expressed, not expressed) for each gene or protein in the network; this
may be difficult to capture with typical microarray data, because discrete state transitions
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are more likely to be conditioned on the level of gene activity, or sequence of changes
over time, rather than whether a gene is on or off. On the other hand, methods of
incorporating the continuous-time character of regulatory networks have been applied to
discrete models of the segment polarity gene network in Drosophila.
While many methods have been developed for the qualitative portrayal of gene
product-association networks, few methods exist for quantifying the interrelated behavior
of genes within these networks. DAGs of interactions based on limited expression data
have been used to portray the quantitative interrelationships of genes as Bayesian
networks. This approach has advantages to formalizing a network because it requires
empirical gene expression data on relatively few samples, it incorporates prior knowledge
about entities in the network, and it can address unknown (hidden) variables in the
potential interactions. A limitation is in modeling relations among a relatively small
number of genes, mainly due to the dimensionality problem of microarray data whereby
the number of gene measurements far exceeds the number of samples being measured.
This tends to restrict analytical models to represent only a small subset of the measured
genes in the network. For example, Bayesian networks were used to model the complex
effects of dioxin on human lung epithelial cells using empirical data collected on 12
genes using eight samples of 27 genes to model a segment polarity gene network in
Drosophila. Other exemplar models used 28 samples of 65 genes and 14 samples of 113
genes. Large numbers of genes (800) are possible when the goal is to identify regulatory
connections rather than to specify network topology. As pointed out in Huang et al.
(2007), the poor scalability of existing techniques typically reveals only an incomplete
structure of a gene regulatory network and these authors proposed the use of scalable
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gene regulatory network learning algorithms based on Bayesian networks and association
rules.
Bayesian networks can be implemented in the R package freely available from the
R Development Core Team (2006). A Bayesian network is a DAG of nodes representing
genes with variable attributes (expression value) and arcs representing gene-dependency
relations. Joint distribution is represented by the variable parameters X(1), , X(n) and
parents (A) of node A. The joint distribution for X(1) through X(n), for example, is
represented as the product of the probability distributions for i = 1 to n. If X has no
parents, then its probability distribution is unconditional, otherwise it is conditional. The
extension to a stochastic process is often employed where we consider the joint
distribution of Xt(1), , Xt(n) and where t is the time variable. Such a dynamic Bayesian
network is appropriate for time-series microarray data. To structure the network, it is
necessary to specify, for each node, the probability distribution of X conditional on its
parents. Conditional distributions depend on unknown or missing parameters; therefore,
iterative fitting techniques such as the expectation-maximization (EM) algorithm may be
used for network optimization. A Markov Chain Monte Carlo (MCMC) algorithm can be
applied to compute posterior distribution, giving a statistic for prediction error. Analysis
of sensitivity-specificity employs parameters specific to each treatment group to run
computer simulations that are conditional on actual experimental data (Figure 4).
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Figure 4. Schema of Bayesian network (BN) and dynamic Bayesian network (DBN) kernels for gene network learning (modeled after E.
Paquet, University of Montreal, http://www.iro.umontreal.ca/~lisa/workshop2004/slides/paquet_slides.ppt). Time-series (sequential) and
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Model refinement using Info tuner couples the simulated results with empirical
data to give significant improvement in both speed and accuracy of the learning
algorithm by replacing the greedy search with novel implementation of the MetropolisHastings-type random walk. Computational models must be validated against empirical
data. Bayesian techniques are particularly suited to treating some of the major difficulties
associated with validation: quantifying multiple sources of error and uncertainty in
reaction models; combining multiple sources of information; and updating validation
assessments as new information is acquired. Several standard methods of sampling from
the probability distribution are available based on a variety of MCMC-type schemes.
Gamma and beta priors for the hypothesized system parameters can give posterior
assessment of the model predictive power and assess how well the model performs. With
that information the model deficiencies could be addressed and the initial model refined.
2.4.2. Critical decisions of a bionetwork
Given that most high-content genomics data is collected on blocks of cells or
tissues, it is important to think about how to anchor Bayesian networks to specific
cellular processes that operate jointly across time and in different parts of the embryo.
Using experimental manipulations such as small interfering RNAs (RNAi), genetic
knockouts, mutations, and drugs or chemicals, one can begin to explore the quantitative
response to specific changes in the network entities (nodes) and relations (arcs). One
approach is to assume that the fundamental molecular interactions have both
deterministic and stochastic components, then simulate networks using a standard
stochastic simulation algorithm and analyze complex behaviors in the perturbed system.
Because disrupting gene function (e.g., knockouts, knockdowns, mutations, and altered
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expression) can perturb embryogenesis, and because various teratogens may reprogram
developmental networks, it is useful to begin to run different simulations on the Bayesian
networks to predict which genes and genetic dependencies can have the greatest impact
on the flow of molecular regulatory information through the network. Thus, once a gene
network structure has been predicted by the bioinformatics and mathematical pipelines
described above, a pathway can be represented as a weighted, directed graph (Young,
Nolte et al. 2008) with a set of vertices, V, representing the genes in the case of a gene
expression network, and a set of edges, E, representing their formal interactions. The
network can then be portrayed with the weights representing the level of importance of
each interaction as measured through the correlation of gene expression values, along
with additional supporting data that may be obtained from external sources such as
transcription factor databases, genotype-phenotype databases and so forth. Figure 5
represents such a gene interaction network for the 14 genes (labeled 0-13) determined
using a Bayesian network approach (see Figure 4). In this simplified example, the
modeled relations indicate that genes 12 and 13 interact with each other, but not with any
of the remaining genes in the network. Given a directed, weighted graph representation, a
number of properties can be determined regarding the interactions. Using graph theory, it
is possible to determine all possible paths beginning at one node and ending at another. In
Figure 5A, two possible paths can link nodes 1 and 11: 123 81011 and 145910 11, based
on current knowledge and empirical data. Since each edge is directed and weighted, the
minimum spanning tree can be determined in more complex schema using Kruskal's
algorithm. This returns the fewest number of interactions needed to have a functional
path.
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Figure 5. Computational perturbation of modeled gene product association networks. A: Network model constructed from the
Bayesian effort illustrated in Figure 4, with a genetic dependency flow for genes 0 to 11. B: Shortest path of information flow
between nodes 0 ? 11 shown in red. C: Model for the removal (e.g., genetic knockout, miRNA knockdown) of two nodes, in this case
nodes 3 and 5, leaving three disjoint gaps in the pathway. D: Emergence of a new connection between nodes 2 and 6 (red arrow),
enabling a new information path from nodes 0 ? 11 and 1 ? 11.
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In addition, the shortest cost and minimum cost paths can be calculated according
to either the number of genes involved in the path, or the weights of the interactions
between the genes. Figure 5B shows a shortest path between genes 0 and 11 in red. Each
of the individual paths in the network potentially represents how the flow of information
might react to physiological signals or perturbations related to development. In the case
of fetal alcohol syndrome, for example, we may envisage qualitative network topologies
that identify sensitive genes and their potential connections, then limit the networks to
those interactions with the strongest weight of evidence for genetic dependencies,
construct Bayesian models to arrange the nodes and edges in the pathway (Figure 4), and
finally impute how a teratogen might disrupt the flow of information across the network
to alter downstream processes. Another step in examining such a graph might be to
determine the set of vertices (V) and edges (E) most vital to network integrity. In other
words, which nodes, when removed, result in a disjoint set that will not allow for
traversal from the first node in the pathway (source) to the final product (sink)? Figure
5C shows what might happen when two critical nodes are removed, while Figure 5D
indicates a single relation that can potentially restore the interaction network. The
resulting effect on the network as a whole can be predicted by traversing the pathway
from input to the output using a shortest cost path approach as with Dijkstra's algorithm,
in which the cost of the path is inversely proportional to the weighted edge. Representing
the pathway as an adjacency matrix of a graph as such can enable each of these steps to
be incorporated and run in a relatively short period of time for a thorough analysis of
individual pathways and to eventually predict outcomes computationally.
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2.4.3. Toward a predictive understanding of developmental toxicity
Multistudy expression profiles have been run across systems of the mouse embryo
during normal development and following teratogen exposure. Although those studies
were limited to microarray gene expression data, an integrative analysis of the mouse
embryonic transcriptome revealed hidden relationships that might not be discovered
without bioinformatics resources. This motivates a continuation of research efforts to
model developmental toxicity at the level of the embryonic transcriptome. Two important
goals are to find a minimal set of genes with adequate discriminating power to categorize
the samples by experimental parameter, and to design a prediction system using the
selected genes to accurately classify unknown samples. Figure 6 presents a conceptual
framework for intelligent model selection in comparative toxicogenomics of birth defects
and developmental disease.
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Figure 7. Conceptual framework for intelligent model selection in comparative toxicogenomics of birth defects and developmental
disease. a: The original microarray data representing the quantitative descriptions of gene expression levels given a specific developmental stressor. b: The original data are randomly divided into Training Data and Test data; each data set has similar sample numbers.
Blue lines represent cleansed data processed through nonlinear principal components analysis PCA (NLPCA); black lines refer to the
uncleansed data. The various paths these data can take are shown by the arrows, e.g.,: Bayesian variable selection (BVS) ? network
analysis through Bayesian networks (BN) or neural networks (NN). c: The corresponding models from each path are depicted as a
manifold in which each ‘‘circle’’ represents a DAG containing the stochastic dependencies of the genes on one another and on the phenotype as quantified by probability density functions. The BN manifold defines an ‘‘order’’ of network models having a ‘‘class’’ of networks linked to the different input conditions (e.g., different sets of significant genes). d: Test data used as input into the DAGs representing the BN models of (c). e: For an unknown sample, the probability of developing the phenotype of interest is represented by the
diamonds and is calculated from the input Test data sets; this probability represents output of (d) when input with test data set. It
allows calculation of the ‘‘true negative’’ and ‘‘true positive’’ rates by comparison with the actual phenotypic expression/nonexpression
of the Test data set. f: The NN manifold defines an ‘‘order’’ of network models having a ‘‘class’’ of networks linked to the different input
conditions; each circle is a NN model consisting of nonprobabilistic nodes (neurons), contrasted to the probabilistic nature of the models in (c), representing nonlinear regression. This establishes a nonprobabilistic mathematical relationship of gene interdependencies
and gene dependency on the phenotype. g: Test data set used as input into the NN models of (f). h: Prediction of phenotypic expression or nonexpression based on input Test data set: allows calculation of the true negative and true positive rates by comparison with
the actual phenotypic expression/nonexpression of the Test data set. AIC and BIC: because multiple data sets may be run for each
order of network models, there will be many model classes to compare. Each class of models can be compared within order (e.g., BNBN, NN-NN) as well as between order (e.g., BN-NN, NN-BN) and the consensus ‘‘species’’ of network models will be used for further
validation. Akaike information criterion (AIC) and Bayesian information criterion (BIC) assist in selection of the optimal species by
essentially scoring the parsimony of the data and finding the optimal number of variables weighed against the model’s error.

Figure 6. Conceptual framework for intelligent model selection in comparative
toxicogenomics of birth defects and developmental disease.

a: The original microarray data representing the quantitative descriptions of gene
expression levels given a specific developmental stressor. b: The original data are
randomly divided into Training Data and Test data; each data set has similar sample
numbers. Blue lines represent cleansed data processed through nonlinear principal
components analysis PCA (NLPCA); black lines refer to the uncleansed data. The
various paths these data can take are shown by the arrows, e.g.,: Bayesian variable
selection (BVS) network analysis through Bayesian networks (BN) or neural networks
(NN). c: The corresponding models from each path are depicted as a manifold in which
each circle represents a DAG containing the stochastic dependencies of the genes on one
another and on the phenotype as quantified by probability density functions. The BN
manifold defines an order of network models having a class of networks linked to the
different input conditions (e.g., different sets of significant genes). d: Test data used as
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the paradigm suggested in Figure
7. The BN approach is described
above; within the field of NN, there
are a variety of network architectures built in MATLAB NN toolbox

gene interdependencies and gene dependency on the phenotype. g: Test data set used as
input into the NN models of (f). h: Prediction of phenotypic expression or nonexpression
based on input Test data set: allows calculation of the true negative and true positive rates
by comparison with the actual phenotypic expression/nonexpression of the Test data set.
AIC and BIC: because multiple data sets may be run for each order of network models,
there will be many model classes to compare. Each class of models can be compared
within order (e.g., BN-BN, NN-NN) as well as between order (e.g., BN-NN, NN-BN)
and the consensus species of network models will be used for further validation. Akaike
information criterion (AIC) and Bayesian information criterion (BIC) assist in selection
of the optimal species by essentially scoring the parsimony of the data and finding the
optimal number of variables weighed against the model's error.
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Predictive modeling in developmental toxicology starting from microarray gene
expression data will require a series of steps, from denoising algorithms to optimal
variable selection and model comparison. The starting data are assumed to have inherent
structure that is related to the biological condition of the test samples and that is
expressed by many variables (e.g., high-dimensional), some having significance to the
phenotype and others not contributing significantly. Many analysis methods of
unsupervised clustering have been described to find the more compact description of the
data (e.g., low-dimensional) and will not be described here. The problem here, however,
is to define an underlying structure in the regulation of the embryonic transcriptome
where the standard learning task identifies gene networks significantly anchored to the
risk of developmental phenotypes.
Nonlinear principal component analysis (NLPCA) is powerful method of data
cleansing that is conceptually a nonlinear extension of the popular principal components
analysis (PCA), which finds the directions of greatest variance in the data set and
represents each data point by its Cartesian coordinates along each axis. The nonlinear
generalization of PCA has been described to transform high-dimensional data into a low
dimensional code (encoder network) and to recover the structured data (decoder network)
under the constraint that initial weights of the data should be close to a solution. NLPCA
is accomplished using an autoassociative neural network, which is a neural network that
has exactly as many output neurons as input neurons, and is trained (an optimization
routine) so that its outputs match its inputs for all data presented. The concept in Figure 6
contains a modified feed-forward multilayer layer perceptron neural network, whereby
input and output layers have linear activation functions to allow recovery of the input
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space; three hidden layers with nonlinear activation functions (sigmoid, tansigmoid, etc.)
give the network nonlinear mapping capability. The middle hidden layer functions as a
bottleneck because it contains fewer neurons than the two other hidden layers or input
and output layers. This limits the autoassociation and thus removes information that does
not contribute to the feature space (e.g., risk for a particular phenotype). Such networks
are very useful in cleansing the data because the network can, knowing what gene
interaction signatures look like, separate the gene pathway data from statistically
insignificant information in a nonlinear way. The output of NLPCA is cleansed or
denoised data, which is then used as input into optimal variable selection techniques
based on Bayesian principles.
Optimal variable selection using the Bayesian paradigm is another powerful tool
to lower dimensionality to focus on entities (variables) that are significant contributors to
the group structure of the data. Two inherent assumptions are as follows: 1) that an
optimal subset of genes can be found (solution) that can account for a particular
phenotype, such as fetal alcohol syndrome; and 2) that most genes do not contribute
significantly to the syndrome. The validity of these assumptions must be confirmed
although they appear to be reasonable given microarray data for experimental fetal
alcohol syndrome in mice. (Tadesse, Sha et al. 2005) developed a data-driven method
that selects discriminating variables into G groups, where G is unknown. This clustering
approach is a multivariate mixture model with an unknown number of components and
uses a binary latent vector that effectively searches through all subsets using the
Reversible Jump Markov Chain Monte Carlo (RJMCMC) algorithm. The reversible jump
aspect of this particular MCMC simply allows movement around different dimensional
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subspaces. Furthermore, this method can predict the class membership of future
observations. The general approach for estimating the parameters of interest uses
Metropolis moves and the RJMCMC, as follows: 1) update parameters from their full
conditions (Gibbs sampler); 2) split one mixture component into two, or merge two into
one (split/merge moves); and 3) birth or death of an empty component (birth/death
moves). The birth/death moves specifically deal with creating/deleting empty
components and do not involve reallocation of the observations (e.g., the entire data
space does not need to be recomputed), hence avoiding doubling-back to unproductive
models and reaching a faster convergence to a posterior. Optimal variables are identified
by selecting those with the largest marginal posterior density. This Bayesian variable
selection (BVS) method is complicated but has been utilized successfully in benchmark
plant (iris) data and DNA microarray data from endometrial cancer patients (Tadesse,
Sha et al. 2005).
To compare different models for critical gene solutions, a manifold of Bayesian
networks (BN) and of neural networks (NN) are computed from the sample data using the
paradigm suggested in Figure 6. The BN approach is described above; within the field of
NN, there are a variety of network architectures built in MATLAB NN toolbox software
that include feed-forward multilayer perceptron networks (The Mathworks, Inc., Natick,
MA). An optimal network of genes associated with a particular risk for malformation,
defined as a species, might be theorized at the convergence of different class models onto
a minimal set of entities (genes) having maximized interactions (relations). In this case, a
tradeoff of complexity in a model versus how well a model fits the data can be assessed
using the Akaike information criterion (AIC) and Bayesian information criterion (BIC)
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that reward goodness of fit and penalize parameters. These statistical methods are rooted
in information theory and are indicative of the parsimony of the final model, where a
decrease in value corresponds to an improved model.
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3. METHODS
3.1. Experimental (animal) studies at RIVM, the Netherlands

Wild type FVB/NHanHsd mice, six to eight-weeks old, were obtained from
Harlan (Horst, NL). All mice were housed in the animal facility in a climate-controlled
room with a 12 h on/off light cycle. Tap water and diets as described below were
provided ad libitum. Animals were monitored daily for general health. The animal
protocol used in this research was reviewed and approved by the Institutional Animal
Care and Use Committee (IACUC) at the University of Louisville. The research was also
approved by the Animal Ethics Committee (IACUC) of the Dutch National Vaccine
Institute (NVI) at Bilthoven, which also serves as the IACUC of the National Institute for
Public Health and the Environment (RIVM) where the animal work was performed for
this study.
All diets used in this experiment were obtained from AB Diets (Woerden, NL).
Mice in the control group were fed a low-fat (5%) regular diet. The high-fat diets
contained 24% fat at the expense of carbohydrates and were based on corn oil (high ratio
of n-6/n-3 PUFAs) or flaxseed oil (low ratio of n-6/n-3 PUFAs) (Chempri
Oleochemicals, Raamsdonksveer, NL).
The study presented here consisted of two dietary exposure groups and one
control group, with differing proportions of polyunsaturated fatty acids (PUFAs). Each
dietary group consisted of 6 females and 3 males. After one week of acclimation to the
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animal room and two weeks prior to mating the dams and sires were shifted from
standard mouse chow to one of the treatment diets. Females were allowed to breed during
one week with the males. Subsequently, dams were housed individually and maintained
on their respective diets through birth and until weaning of their litters. The number of
pups born alive was recorded at the day of parturition, designated postnatal day (PND) 0.
Body weights of all pups were recorded on PND 1, PND 7, and PND 14. After weaning
on PND 21, male pups were euthanized by carbon dioxide asphyxiation. F1 female pups
were kept on the appropriate treatment diets until 6 weeks of age. At 6 weeks the F1
female mice were shifted to the standard low-fat (5%) chow until terminal sacrifice at 10
weeks of age. Body weights of F1 female pups (n = 21 for the control group, n = 12 for
the high-fat corn oil group, and n = 15 for the high-fat flaxseed oil group) were recorded
weekly from PND 21 until 10 weeks of age. At autopsy, blood and major organs were
isolated from each animal, including the fourth abdominal mammary gland on the right
side of the mouse, liver, kidney and spleen. The mammary gland was kept in RNAlater
RNA stabilization Solution (Ambion, Austin, Texas) at 4 °C for maximally 14 days;
other organs were snap frozen in liquid nitrogen. A schematic overview of the study
design is depicted in Figure 7.
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Figure 7. Study design
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3.2. RNA isolation and microarray analysis

DNA/RNA was extracted by using AllPrep DNA/RNA mini isolation kit (Qiagen,
Valencia, CA, USA). RNA samples were treated with the RNase-Free DNase set
(Qiagen) and concentrations were measured using a NanoDrop Spectrophotometer
(NanoDrop Technologies, Wilmington, DE, USA). RNA was assessed for quality with
the Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA). Both the RNA
integrity number and the presence of degradation products were checked.
The mouse oligonucleotide libraries (catalog no. MOULIBST and
MOULIB384B) were obtained from Sigma-Compugen, Inc. Technical support was
supplied by LabOnWeb (http://www.labonweb.com/cgi-bin/chips/full_loader.cgi). The
libraries represent in total 21,766 LEADS™ clusters plus 231 controls. The
oligonucelotide library was printed with a Lucidea Spotter (Amersham Pharmacia
Biosciences, Piscataway, NJ, USA) on commercial UltraGAPS slides (amino-silanecoated slides, Corning 40017) and processed according to the manufacturer's instructions.
The slides contained 65-mer oligonucleotides, and the batch was checked for the quality
of spotting by hybridizing with SpotCheck Cy3-labeled nonamers (Genetix, New Milton,
Hampshire, UK).
Total RNA samples were hybridized in randomized batches, according to a
common reference design without dye swap. An RNA pool of all samples isolated was
used as a common reference. From the total RNA samples with an RNA integrity number
value of >7, 1.0 µg was amplified using the Amino Allyl MessageAmp amplified RNA
kit (Ambion) and labeled with Cy5 (experimental samples) and Cy3 (common reference)
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reactive dye according to the manufacturer's instructions. The microarrays were
hybridized overnight with 200 µl hybridization mixture, consisting of 50 µl Cy3- and
Cy5-labeled amplified RNA (with 150 pmol Cy3 and 150 pmol Cy5), 100 µl formamide,
and 50 µl 4× RPK0325 microarray hybridization buffer (Amersham Pharmacia
Biosciences), at 37°C, washed in an automated slide processor (Amersham Pharmacia
Biosciences), and subsequently scanned at two wavelengths using a ScanArray 4000XL
microarray scanner (Perkin-Elmer, Waltham, MA, USA). Median Cy3 and Cy5 signal
intensities per spot were determined using Array Vision software (Imaging Research, St.
Catharines, Ontario, Canada).
In total, 28 two-color mouse genome (M. musculus) cDNA microarrays were used
in this study, representing 4 batch groups: Groups A and B (n =6 each) were from the 5%
fat diet (control) groups, and Groups C and D (n =8 each) were from the treatment
groups. The microarray processing was done on 4 different dates, and all groups were
processed on each of these days; therefore, treatment is not nested within batch. For
purposes of the analysis, the two control groups were combined (n =12).
3.3. Pre-processing of microarray dataset
Microarray quality control was performed on raw data by means of visual
inspection of the scanned images, as well as a check on the scatter and MA plots. Image
plots, box plots, MVA plots, and histograms were used to assess data and microarray
processing quality. The image plots show that several arrays had large areas with cold
spots during some of the runs. One of the arrays (A3) had close to 30% of its area taken
up by cold spots. There is a potential that these spots had an adverse affect upon the
analysis. Normalization methods cannot be relied upon to eliminate the effect of large
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cold spots. The BioConductor software packages arrayQuality and marray were used to
assess array quality. An offset of 50 was used for background correction to avoid
negative or zero corrected intensities and to preserve variance for analysis of differential
expression. Locally weighted regression was used to normalize within arrays. Finally,
quantile normalization was performed across arrays because of the large variation
between arrays seen in the box plots (Figure 8).
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Figure 8. Boxplots before and after normalization
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3.4. Microarray data analysis
Several data analysis models were used to identify genes that were differentially
expressed between the treatment groups and the control group.
3.4.1. Method 1 – analysis of variance, hierarchical clustering
In the first model, two-way analysis of variance (ANOVA) was employed that
takes into account the batch effect (date of microarray processing) as well as the
treatment effect. Treatment effect was included last in the model to account for the
unbalanced design. To correct for multiple testing, Benjamini-Hochberg’s false discovery
rate (FDR) (Benjamini and Hochberg 1995) was used with a cut-off of 0.05. The F1
statistics were used for gene set enrichment analysis (GSEA) (Mootha, Lindgren et al.
2003). All pathways present in the c4 database of the Molecular Signatures Database
(MSigDB 2.0; http://www.broad.mit.edu/gsea/msigdb/msigdb_index.html) were tested
for significance.
Hierarchical clustering was employed using Euclidian distance as a dissimilarity
measure. In addition, the DAVID ‘Functional Annotation Clustering’ tool (Dennis,
Sherman et al. 2003) was used to cluster the 99 genes into different groups (more than
15). The method allows genes to belong to more than one group.
3.4.2. Method 2 – principle component analysis, analysis of variance
In the second model, ratiometric values (test/reference) were transformed to log2
and normalized with Lowess smoothing. Batch and litter-size effects were removed using
Partek Genomics Suite v 6.3 (Partek Inc.; www.partek.com) and the residual variance
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was analyzed by Principal Components Analysis (PCA), one-way ANOVA (P ≤ 0.005)
and specific group comparisons. All data was mean-centered and quantile normalized to
make the gene expression distributions across the different microarrays similar. This
analysis returned 670 genes for subsequent cluster analysis and functional annotation.
3.4.3. Method 3 – Bayesian variable selection
In the third model, a Bayesian-based variable selection (BVS) algorithm was
applied. A systematic methodology for identifying optimal discriminative gene subsets in
the analysis of this data (controls and flax) is adopted via a Bayesian-based variable
selection algorithm (BVS) utilizing the stochastic search technique. BVS analysis was
implemented in MATLAB (The MathWorks, Inc. 3 Applehill Drive, Natick, MA 017602098) using code available from Marina Vannucci (Bayesian variable selection in
multinomial probit models 2004 - http://www.stat.rice.edu/~marina/codes.html) (Sha,
Vannucci et al. 2004), additional coding written in MATLAB. The MATLAB
Bioinformatics Toolbox 2.5 was utilized in generating heatmaps and gene ontology
enrichment.
Vannucci (P. J. Brown 1998) implemented a BVS methodology that builds upon
the stochastic search variable selection technique (SSVS). The idea of SSVS is to embed
a linear regression model into a hierarchical Bayes model, where regression coefficients
are given mixture priors. Vannucci’s code extended the model to the general multivariate
case for probits and multinomial classification (Sha, Vannucci et al. 2004). This is
accomplished through the use of latent (unobserved) variables representing the
categorical response. Introduction of latent data (data augmentation) into the model
allows the probit model to be transformed into a linear regression problem in the
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multivariate normal context. Essentially, the entire regression model is embedded into a
hierarchical Bayes normal mixture model, where latent variables are used for subset
selection. A key idea for variable selection in this context is introduction of a binary pvector γ that indexes all possible variable subsets. More specifically, the jth element of
the latent binary p-vector γ ,γj , is 0 or 1, corresponds to inclusion or exclusion of a
particular variable in the gene subset. This vector takes 2p values. Elaborating on the
priors of the regression coefficients by assuming the coefficients come from a normal
mixture facilitates assessment of the importance of a variable in the model. The prior
distributions of γj’s are set as independent Bernoulli (collectively Binomial).
Through appropriate prior elicitation and integration of parameters out of the joint
posterior, the posterior distribution of all possible subsets given the data can be derived
but is of unknown form. This posterior space is searched via Metropolis-Hastings using
add/delete/swap Metropolis moves. More specifically, a fast-inference scheme is adopted
by deriving the marginal posterior distribution of the latent vector γ given the data by
integrating out other parameters from the joint posterior distribution (Sha, Vannucci et al.
2004). Again, the distribution of γ is not of known form and is explored using Markov
Chain Monte Carlo (MCMC), where the Markov Chain is constructed using the
Metropolis-Hastings algorithm. The composition of the variable subset (i.e. genes)
evolves as we iterate through in the MCMC context by searching the 2p space using
add/delete/swap Metropolis moves (add/delete: randomly choose one of the p indices in
γold and change its value from 0 to 1 (add), or from 1 to 0 (delete), to become γnew; swap:
independently choose and at random a 0 and a 1 in γold, switch their values to get γnew).
Subsets and variables with a higher joint posterior probability can be identified by more
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frequent occurrence in the MCMC output. As a result, posterior inference of γ, and thus
the composition of the variable subsets, is completely data-based after hyperparameter
specification. Prediction performance of these gene subsets is assessed using a samplingbased cross-validation prediction procedure due to the small number of microarrays in
relation to the large number of variables.
A key attractive feature of this technique is that it assesses the joint effects of the
variables. Two variables independently may not be descriptive given the observed data,
but in conjunction, are valuable predictors. Because variable subsets are selected on the
basis of maximal joint posterior density, the subsets will inherently attempt to avoid
correlation of included variables, as inclusion of an additional highly-correlated variable
(at the expense of a potentially valuable predictor) into a model brings no additional
predictive power, leading to no increase in joint posterior probability. Data for this
technique must be pre-processed by mean-centering and rescaling by variable range.
Advantages of this implementation are that the subset selections assess the joint effect of
variables in attempting to account for the discriminative changes seen in the response
data and that this procedure truly determines how “valuable” a variable is. Disadvantages
are computational demands due to the vast and highly complex posterior space (defined
on all possible subsets, 2p), where it may not be possible to efficient search over the space
in extremely large datasets. Also, there is risk that the MCMC procedure does not
converge to the posterior distribution within a reasonable timeframe. This can be
minimized by running multiple chains for long periods, discarding all but the last
iterations, and pooling the MCMC. Prior specification is also an issue, although the
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authors give procedures for calibration of the priors from the data and from theoretical
constraints (avoiding Lindley’s Paradox). The SSVS schema is shown in Figure 9.
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Figure 9. Layout of stochastic search variable selection technique
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Hyperparameters controlling model shrinkage, prior probabilities of variable
inclusion, and model expectation size were all specified. The parameter related to total
relative prior to posterior precision was taken as the average of the values corresponding
to 0.1 and 0.005. This specific hyperparameter regulates the amount of shrinkage in the
model and is related to the ridge regression. Prior probabilities of variable inclusion are
assigned independent Bernoulli trials where p is assigned ½. Because it is expected and
desired to have few genes in the gene subset, the binomial prior for the chosen variables
(genes) in γ is set to have an expectation of 10, so that the MCMC procedure tends
toward the space of smaller models. MCMC was run for 500,000 iterations, where the
first 100,000 were discarded as burn-in. The starting γ vector was taken with 10 randomly
selected genes included.
Vannucci et al. have extended variable selection to incorporation in clustering highdimensional data. Future work may be done to explore the cluster structure and
associated significant variables (Sinae, Mahlet et al. 2006) (Tadesse, Sha et al. 2005).
3.5. Fatty acid profiling of exposure diets and mouse sera (RIVM)

Fatty acid composition was analyzed both in the various animal diets and in a
representative number of sera obtained from mice fed these diets. Methods were adapted
from procedures described earlier (Mamalakis, Jansen et al. 2006). Fatty acids have been
expressed as percent of the total fatty acids present in the chromatogram.
3.6. Statistical analyses
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General statistical procedures were performed with either SPSS version 12.0.1 or
S-PLUS 2000 statistical software packages. All values were expressed as means ±
standard deviations when appropriate. Reproductive parameters and pup weights of PND
1 were analyzed using one-way ANOVA. Body weights of female pups from 3 to 10
weeks of age were analyzed using a nonlinear mixed effects model. The nonlinearity is
formed by an

asymptotic

growth model, in which the weight yij of mouse i at time tj is modeled as:

43

4. Results
4.1. Phenotype anchors (RIVM)

Maternal dietary exposure to a high-fat diet, rich in either n-6 or n-3 PUFAs, did
not result in significant effects on pregnancy rate, litter size or sex ratio (data not shown).
The number of female pups born in each dietary group was n = 21 for the control group,
n = 12 for the high-fat corn oil group, and n = 15 for the high-fat flaxseed oil group.
4.2. Fatty acid profiling

To investigate whether perinatal exposure to treatment diets high in n-6 or n-3
PUFAs was still detectable at time of sacrifice (i.e. 4 weeks after cessation of treatment),
fatty acid profiling of a representative number of mouse sera was performed. The n-6/n-3
PUFA ratio is about threefold higher in mice fed a diet based on corn oil as compared
with mice fed a diet based on flaxseed oil. These results indicate that perinatal exposure
to high-fat diets with either high or low n-6/n-3 PUFA ratios has a lasting effect on the
fatty acid profile of the serum.
4.3. Postnatal body weight gain (RIVM)

Postnatal body weight trajectories are shown in Figure 10. At PND1, no statistically
significant difference in body weight of the pups between any of the groups was
observed. However, at 3 weeks of age, female pups from the high-fat diet groups, based

44

on either corn or flaxseed oil, were significantly heavier than female pups from the lowfat diet (P < 0.001). In addition, body weights of F1 female pups from the high-fat diet
groups increased more rapidly than from the control group (P < 0.001). At 10 weeks of
age, body weights of the F1 female pups perinatally fed a high-fat diet based on corn oil
were no longer significantly different from the control group. In contrast, female pups
perinatally fed a high-fat diet based on flaxseed oil were still heavier than pups from the
control group (P < 0.001), despite the fact that they were shifted to a low-fat diet from 6
weeks of age onwards. Postnatal body weight trajectories of F1 females sustained on the
high-fat diet based on flaxseed oil paralleled the normal growth curve, but these test
animals remained heavier by a constant scalar. In contrast, the growth curve of females
sustained on the high-fat diet based on corn oil approached the regular trajectory. The
slight dip in trajectories at 3 weeks of age is accounted for by the removal of male pups,
which are slightly heavier than females.
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Figure 10. Developmental programming of growth trajectories in female FVBn mice
Test diets were given maternally, from preconception through lactation (3-weeks), and
after weaning to early juvenile life (6-weeks of age). The increased weights of high-fat
diets were significant versus regular diet at 3-weeks and beyond; however, females from
the fatty corn oil diet shifted to the regular trajectory between 6- and 10-weeks of age.
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4.4. Mammary gland gene expression
Gene expression profiling of the 4th right abdominal mammary gland was
determined on postnatal week 10. We used two different data analysis models. In the first
model, statistical analysis using a two-way ANOVA and false discovery rate cut-off at
P=0.05 returned 99 differentially expressed genes across the dietary groups. Pathway
inference performed using the R package GSA (Gene Set Analysis) focused on a gene set
from Molecular Signature Databases (MSigDB) defined by expression neighborhoods
centered on 380 human cancer-associated genes, of which there were 28 gene sets with
fdr less than or equal to 0.10. Functional annotation chart from DAVID showed weak
representation of only one KEGG pathway at that same level (natural killer cell mediated
cytotoxicity).
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Figure 11. Heatmap of 99 differentially expressed genes

48

Figure 12. DAVID results showing one KEGG pathway (using significant genes as
input)
Note: one limitation of the pathway analysis performed using GSA is that the gene set
from the Broad Institute contains genes from the human genome, and the microarray
experiment contains genes from the mouse genome. The genes from the KEGG pathways
contain gene symbols from both human and animal. In this analysis, all gene symbols
were converted to upper-case, so that the analysis was across species.
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In the second statistical model, one-way ANOVA identified 670 genes that
accurately classified samples by maternal diet exposure and PCA showed clear evidence
of clustering by diet group (Figure 13B). Class differences were greatest between regular
(5% fat) diet and high-fat (24%) based on flaxseed oil groups, with the corn oil group
being intermediate in its response. This pattern was similar to that observed for body
growth curves (Figure 10). Differential transcript abundance profiles could be partitioned
neatly into two clusters of genes (Figure 13C). One cluster had 240 genes with downward
programming by flaxseed oil. Gene Ontology (GO) scores enriched this cluster for
biological themes to metabolism pathways: oxidative phosphorylation, TCA cycle, fatty
acid metabolism, glyocolysis/gluconeogenesis, propanoate metabolism, and pyruvate
metabolism. The other cluster had 430 genes with upward programming by flaxseed oil.
GO scores enriched this cluster for morphoregulatory pathways: cell adhesion molecules
and cytokine pathways. We may conclude from these results that maternal dietary fat
exposure significantly influenced metabolic programming, and signaling networks in the
mammary gland of female offspring.
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Figure 13. Developmental programming of gene expression in the mammary gland
Test diets (Figure 1) given to 6-weeks of age, and regular diet thereafter. Microarray
analysis performed at 10-weeks of age; sources of variation identified for litter-size,
treatment, and batch. After removing litter / batch effects the source of variance was
plotted for regular diet (blue, red; n=12), fatty-diet corn oil (green, n=8) and fatty-diet
flaxseed oil (magenta, n=8) using PCA. The heat-map shows clustering of 670
differentially-regulated genes (horizontal) and samples (vertical)
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4.5. Discriminatory genes identified through BVS

Because PCA is a popular dimension-reduction tool in statistical models but as a
compression technique basically categorizes data by variance, using a linear
transformation to shift coordinate systems and compute values in the rotated coordinate
system. By doing so, PCA decorrelates the inputs and makes them orthogonal; however,
this linear decomposition is not inimical to gene interactions that are highly nonlinear and
correlated. Also, PCA does not assess the joint effect of multiple variables and does not
allow for evaluation of the original variables. Singular value composition, a very closely
related concept (from which PCA can be derived), has also been applied to gene
expression data to reduce dimensionality, but again, with the same problems.
Because the BVS algorithm does not scale well above ~1000 variables and has
not been rigorously tested above this threshold, BVS was run on an ANOVA (P <
0.0055) gene set comprising 914 genes. The algorithm was run using the control
(isocaloric) and flaxseed groups only. This was done because the algorithm performs
optimally under binary classification, although the method has been extended to the
multinomial setting. Because of the restriction to the binary classification setting, the two
groups were chosen by those with largest group weight divergence (isolcaloric vs.
flaxseed). Distinct visited gene models (subsets) were sorted according to normalized
joint posterior probability. Interesting gene subsets were chosen as the union of the top 10
models via normalized joint posterior probability. Gene subsets can also be selected via
top marginal density. In fact, optimal gene selection via both joint posterior density and
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marginal density resulted in very similar gene sets. The union of the top 10 models via
joint posterior density resulted in a 17 gene subset (Table 1).
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Table 1. Nomenclature of the 17 gene subset (Bult CJ 2008)

Input

MGI
Gene/Marker
ID

Symbol

Name

Marker
Type

M33425

MGI:96628

Jak1

Janus kinase 1

Gene

NM_025543 MGI:1913655

Mcts2

malignant T cell
amplified sequence 2

Gene

AB008179

Pcdha7

protocadherin alpha 7

Gene

NM_011073 MGI:97551

Prf1

perforin 1 (pore
forming protein)

Gene

NM_008404 MGI:96611

Itgb2

integrin beta 2

Gene

Cmtm7

CKLF-like
MARVEL
transmembrane
domain containing 7

Gene

Me1
Agrn

malic enzyme 1,
NADP(+)-dependent,
cytosolic
agrin

Gene
Gene

NM_007378 MGI:109424

Abca4

ATP-binding
cassette, sub-family
A (ABC1), member 4

Gene

BC008156

Usp43

ubiquitin specific
peptidase 43

Gene

Gpr137b-ps

G protein-coupled
receptor 137B,
pseudogene

Gene

Pld3

phospholipase D
family, member 3

Gene

AF188504

MGI:1298369

MGI:2447166

NM_008615 MGI:97043
AF294811
MGI:87961

AF154337

MGI:2444541

MGI:3710533

NM_011116 MGI:1333782
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Inpp4a

inositol
polyphosphate-4phosphatase, type I

Gene

Ncf2

neutrophil cytosolic
factor 2

Gene

Aatk

apoptosis-associated
tyrosine kinase

Gene

NM_007781 MGI:1339760

Csf2rb2

colony stimulating
factor 2 receptor, beta
2, low-affinity
(granulocytemacrophage)
Gene

NM_011581 MGI:98738

Thbs2

thrombospondin 2

AF317838

MGI:1931123

NM_010877 MGI:97284

NM_007377 MGI:1197518
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Gene

Figure 14. Heatmap of 17 genes from Bayesian variable selection, representing the
union of the top 10 models via top posterior density
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Table 2. List of genes in the 17 gene subset upregulated and their respective
functions (per GeneGo) (Bult CJ 2008)
MGI

Gene
Symbol

Gene Name

Goid

MGI:96628

Jak1

Janus kinase 1

GO:0019221
GO:0007167
GO:0018108
GO:0007243
GO:0004713
GO:0005524
GO:0005856
GO:0004718
GO:0016301
GO:0016020
GO:0004715
GO:0000166
GO:0006468
GO:0004672
GO:0016740
GO:0005515

MGI:97551

Prf1

perforin 1 (pore
forming
protein)

MGI:96611

Itgb2

integrin beta 2
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Code
cytokine and chemokine
mediated signaling
pathway
enzyme linked receptor
protein signaling
pathway
peptidyl-tyrosine
phosphorylation
protein kinase cascade
protein tyrosine kinase
activity
ATP binding
cytoskeleton
Janus kinase activity
kinase activity
membrane
non-membrane spanning
protein tyrosine kinase
activity
nucleotide binding
protein amino acid
phosphorylation
protein kinase activity
transferase activity
protein binding

GO:0019835 cytolysis
cytoplasmic membraneGO:0016023 bounded vesicle
GO:0005509 calcium ion binding
GO:0016021 integral to membrane
GO:0016020 membrane
GO:0005615 extracellular space
GO:0009986 cell surface
integrin-mediated
GO:0007229 signaling pathway
GO:0005624 membrane fraction
GO:0045121 membrane raft

GO:0005488
GO:0007160
GO:0008305
GO:0016020
GO:0005515
GO:0004872

MGI:2447166 Cmtm7

CKLF-like
MARVEL
transmembrane
domain
containing 7

GO:0050798
GO:0007155
GO:0045123
GO:0030593
GO:0016021

binding
cell-matrix adhesion
integrin complex
membrane
protein binding
receptor activity
activated T cell
proliferation
cell adhesion
cellular extravasation
neutrophil chemotaxis
integral to membrane

GO:0006935
GO:0005125
GO:0005615
GO:0016020
GO:0016021

chemotaxis
cytokine activity
extracellular space
membrane
integral to membrane

Gpr137bMGI:3710533 ps
G protein-coupled receptor 137B, pseudogene
phospholipase
D family,
MGI:1333782 Pld3
member 3
GO:0003824 catalytic activity
GO:0005783 endoplasmic reticulum
GO:0016787 hydrolase activity
GO:0016042 lipid catabolic process
GO:0016020 membrane
GO:0008152 metabolic process
GO:0005624 membrane fraction
GO:0004630 phospholipase D activity
GO:0016021 integral to membrane
neutrophil
cytosolic factor
MGI:97284
Ncf2
2
GO:0001669 acrosome
GO:0005737 cytoplasm
GO:0005488 binding
GO:0005829 cytosol
GO:0006742 NADP catabolic process
superoxide metabolic
GO:0006801 process
GO:0016175 superoxide-generating
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NADPH oxidase activity

MGI:1339760 Csf2rb2

colony
stimulating
factor 2
receptor, beta 2,
low-affinity
(granulocytemacrophage)

GO:0019221
GO:0004896
GO:0004907
GO:0016020
GO:0004872
GO:0016021

MGI:98738

Thbs2

thrombospondin
2
GO:0005509
GO:0007155
GO:0005576
GO:0008201
GO:0005515

cytokine and chemokine
mediated signaling
pathway
hematopoietin/interferonclass (D200-domain)
cytokine receptor activity
interleukin receptor
activity
membrane
receptor activity
integral to membrane

calcium ion binding
cell adhesion
extracellular region
heparin binding
protein binding
structural molecule
GO:0005198 activity
GO:0005615 extracellular space
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Table 3. List of genes in the 17 gene subset downregulated and their respective
functions (per GeneGo) (Bult CJ 2008)
Gene
Symbol Gene Name
malignant T
cell amplified
MGI:1913655 Mcts2
sequence 2
MGI

MGI:109424

Abca4

ATP-binding
cassette, subfamily A
(ABC1),
member 4

Goid

Code

GO:0005737 cytoplasm
regulation of
transcription, DNAGO:0006355 dependent
GO:0006350 transcription
GO:0003723 RNA binding

GO:0005524 ATP binding
GO:0016887 ATPase activity
integral to
GO:0016021 membrane
GO:0016020 membrane
nucleosidetriphosphatase
GO:0017111 activity
GO:0000166 nucleotide binding
GO:0050896 response to stimulus
GO:0006810 transport
phospholipid
transfer to
GO:0006649 membrane
phospholipid
GO:0005548 transporter activity
phospholipidtranslocating
GO:0004012 ATPase activity
photoreceptor cell
GO:0045494 maintenance
GO:0007601 visual perception
ATPase activity,
coupled to
transmembrane
GO:0042626 movement of
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substances
integral to plasma
GO:0005887 membrane

MGI:1931123 Inpp4a

inositol
polyphosphate4-phosphatase,
type I
GO:0016787 hydrolase activity
phosphatidylinositol3,4-bisphosphate 4GO:0016316 phosphatase activity
polyphosphate
GO:0006798 catabolic process
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Gene ontology (GO) enrichment for the 17 genes was performed using both
biological process and molecular function ontologies. Code written in MATLAB4
grabbed GOids (biological process and molecular function) associated with each gene in
the subset. To get a systems-level appreciation of these GOids, expression values of
genes (in the original BVS analyzed dataset (P < 0.0055)) having membership to subsetderived GOids (from the 17 gene subset) were grabbed and for each subset-derived GOid,
the constitutive gene expression levels were averaged. For example, a biological process
GOid of the 17 gene subset is ‘neutrophil chemotaxis.’ The gene expression profiles of
all genes having membership to this GOid in the P < 0.0055 geneset were averaged. This
provides information on the behavior of this ‘neutrophil chemotaxis’ GOid on the basis
of its constituent genes’ expression profiles. Because the GOids have now been
characterized with gene expression data (from their constituentive genes), the GOids can
be visualized using heatmaps (Figure 15 and Figure 16). Furthermore, the 17 gene subset
was able to correctly classify all control and flax pups as either a control or flax group
member using a sampling based cross-validation procedure (
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Table 4). This analysis clearly correlates a decrease in expression of metabolism (energy)
pathways with a reciprocal increase in cytokine and inflammatory (adipocytokine)
signaling pathways. More specifically, upward programming was seen in chemotaxis,
cell adhesion, cytokine and integrin pathways, T-cell and neutrophil activity, and
cytolysis. Downward programming was seen chiefly in metabolic pathways. These
findings suggest a developmental reprogramming of pathways in energy metabolism
(decreased) and adipocytokine (increased) signaling, linked with the body weight defect
between the flaxseed and control diets in mammary tissue.
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Table 4. 100% classification rate for control and flax pups using the 17 gene subset
Pup Group Prediction Group Prediction Actual Group
0= control
0= control
0= control
1 = flax
1 = flax
1 = flax
1
0.0304
0
0
2
0.1214
0
0
3
0.0358
0
0
4
0.031
0
0
5
0.0355
0
0
6
0.0524
0
0
7
0.0406
0
0
8
0.0709
0
0
9
0.0462
0
0
10
0.0413
0
0
11
0.0591
0
0
12
0.0439
0
0
13
0.9786
1
1
14
0.9202
1
1
15
0.9386
1
1
16
0.9682
1
1
17
0.9565
1
1
18
0.8816
1
1
19
0.85
1
1
20
0.9779
1
1
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Figure 15. Heatmap of biological process GOids from the 17 genesubset (from
Bayesian variable selection representing the union of the top 10 models according to
posterior density)
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Figure 16. Heatmap of molecular function GOids from the 17 gene subset (from
Bayesian variable selection representing the union of the top 10 models according to
posterior density)
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Figure 17. Reciprocal behavior between energy and immune pathways
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To further explore this reciprocal relationship MetaCoreTM V 5.0 analysis Suite
from GeneGO Inc. was used to generate a genetic network of the adipocytokine pathway
based on gene expression values of pathway genes in the entire microarray data set
(Figure 18). A canonical representation of the adipocytokine pathway in KEGG was
colored for expression levels using GeneSpring GX 7.3, Agilent Technologies Inc.
(Figure 19).
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Figure 18. Adipocytokine pathway
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In the pathway, primarily immune-related and signaling pathways were upregulated, and in general, metabolic pathways were down-regulated (Figure 17). These
are shown in Table 5 and Table 6 respectively.

70

Table 5. Up-regulated adipocytokine pathway genes
Up
Gene Symbol
*JAK1
SOCS3
PKC-theta
AKT1
IKK-gamma
IKK
(cat)(IKBKG)
NFKBIE
NFkb
- RELA
- RELB
- REL
- NFKB2
LTA
CD36
SLC2A2

Protein
JAK1
SOC3
KPCT
AKT1
IKKB

Protein Name
Tyrosine-protein kinase JAK1
Supressor of Cytokine Signaling
Protein kinase theta type
RAC-alpha serine/threonine-protein kinase
Inhibitor of nuclear factor kappa-B kinase subunit
beta

NEMO
IKB

NF-kappa-B essential modulator
NF-kappa-B inhibitor epsilon

TF65
RELB
REL
NFKB2
TNF-beta
CD36
GTR2
(GLUT2)

Transcription factor p65
transcription factor RelB
C-Rel proto-oncogene protein
Nuclear factor NF-kappa-B p100 subunit
Lymphotoxin-alpha precursor
Platelet glycoprotein 4
Solute carrier family 2, facilitated glucose
transporter member 2
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Table 6. Down-regulated adipocytokine pathway genes
Down
Gene Symbol
PPARbeta(delta)/RXRalpha
IRS-4
SLC2A1
SLC2A4
SLC2A5
NPY1R
RXRG

Protein

Protein Name

PPARD
IRS-4
GTR2
(GLUT1)
GTR4
(GLUT4)
GTR5
(GLUT5)
NPY1R
RXRG

Peroxisome proliferator-activated receptor cells
Insulin-receptor substrate 4
Solute carrier family 2, facilitated glucose
transporter member 1
Solute carrier family 2, facilitated glucose
transporter member 4
Solute carrier family 2, facilitated glucose
transporter member 4=5
Neuropeptide Y receptor type 1
Retinoic acid receptor RXR-gamma
Carnitine O-palmitoyltransferase 2, mitochondrial
precursor
Peroxisome proliferator-activated receptor gamma
coactivator 1-alpha'
Adiponectin receptor protein 2
Phosphoenolpyruvate carboxykinase, cytosolic
[GTP]
Carnitine O-palmitoyltransferase I, muscle isoform

CPTII
PPARGC1
(PGC1-alpha)
AdipoR2

CPT2

PCK1
CPT-1B

PPCKC
CPT1B

PRGC1
ADR2
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Genespring (VERSION GX7.3, 5301 Stevens Creek Blvd, Santa Clara CA 95051,
United States) was used to generate a canonical representation of the adipocytokine
pathway using expression data via KEGG and is represented in Figure 19. Of the 22680
Genbank Ids, 17487 and 21551 were mapped to unique gene IDs and EntrezGene IDs
respectively.
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Figure 19. Canonical adipocytokine pathway per KEGG using Genespring
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5. DISCUSSION
The adipocytokine pathway experienced a number of changes, with up and downregulated groups of genes showing displaying biological themes. Up-regulated genes
primarily present protein kinase casacde and immune response pathways, whereas downregulated genes are indicative of metabolic pathways. These genes, their biological
functions, and relevance to oncogenesis and obesity are included in Table 7 and Table 8.
More specifically, JAK-1 was independently implicated in potential relevance to
high-fat fetal reprogramming by BVS and by pathway analysis, where the adipocytokine
pathway displayed a large number of gene expression changes in constitutive genes.
JAK-1 is a key component of the intracellular signaling cascade, and is an upstream
effector of downstream transcript modulation of immune processes in particular. It is
intimately involved in cytokine signaling and plays a role in initiaing such responses.
JAK-1 stimulates stat5, a conventional prolactin signalling protein. Moreover, JAK-1
also recuits new signals, such as stat3 and ERK. These are considered to be tumorpromoting in breast tissue (Lee, Joung et al. 2006). It is interesting that JAK-1 retained
such high expression in ex high-fat pups. This prolonged over-expression may effect
many downstream changes, especially involving inflammatory processes, that are related
to the pathogenesis of breast carinoma. As some of these genes and pathways have been
implicated in promoting breast cancer development, JAK-1 inhibitors may be useful for
breast cancer treatment. Another signal transduction element displaying over-expression
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is protein kinase B (AKT-1), which is critical for transmitting growth signals. Also,
AKT-1 is responsible for inactivating components of the apoptosis. Moreover, AKT-1
expression have been implicated in accelerated breast tumourigenesis (Young, Nolte et
al. 2008). Increased AKT-1 expression is also found with increased serum insulin levels,
as insulin activates AKT-1 and 2. High insulin levels will lead to insulin resistance.
Small heterodimer partner 2 (SHP-2) is a cytoplasmic SH2 domain and is
involved in signaling pathways for growth factors and cytokines. This gene displayed upregulation in pups dosed with high-fat diets. Particularly, it is a critical intracellular
regulator in mediating cell proliferation and differentiation. Given this function, and its
positive relationship with lymph node metastasis and tumor grade, it has been suggested
that SHP2 promotes breast oncogensis (Zhou, Coad et al. 2008). It is important to note
that SHP2 effects downstream transciption changes of epidermal growth factor receptor
(EGFR) and enhances EGFR activity during mouse growth and development (Qu, Yu et
al. 1999). EGFR has been implicated in the breast carcinoma pathogensis.
AMP-activated protein kinase (AMPK) was significantly down-regulated.
AMPK’s net effect is fatty acid oxiation, where lipogensis is inhibited. Interestingly,
adiponectin expression is high in both control and dosed groups, where the dosed group
had even higher expression, which is contrary to the observation that in obesity,
adiponectin expression is typically markedly depressed. This observation is not well
understood in infants and children, and as tissue sections were collected when mice were
in puberty, the high adiponectin expression and obesity are probably not related. This is
supported by the observation that adiponectin transcripts are over-expressed in
adipogenic tissues (during development and differentiation). Adiponectin receptor
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(ADIPOR-2) displayed marked decreased expression and is likely due to the diet-induced
obesity and regulatory feedback from high expression of adiponectin. This would reduce
adiponectin sensitivity, which would eventually lead to insulin resistance, a consequence
of the adipocytokine pathway when showing decreased metabolic processes and
increased cytokine/inflammatory pathways.
Neuropeptide Y receptor 2 (RPY-2R) expression was significatly increased,
which effects decreased food intake (appetite) and adipogenesis. These, as a result of
diet-induced obesity, also lead to insulin resistance. Most of the genes showing
significant down-regulation are related to metabolic processes. CPT-1 was significantly
down-regulated, and is responsible for fatty acid oxidation and transport of long chain
fatty acids across the mitochondrial membrance (binds them to carnitine). Also, acetylCoA carboxylase 2 (ACC-2) is another key regulator of mitochondrial fat oxidation that
displayed downward expression in the experimental groups. It has been noted in the
litertaure that ACC-2 negative mice have a normal lifespan, and that ACC-2 targeted
inhibition may be a viable therapeutic option for the treatment of obesity and type 2
diabetes mellitus.
These metabolic processes do not demonstrate the relationship to breast
carcinogensis as do the signal tranduction and regulatory immune processes that
underwent significant upward cellular response reprogramming. However, they do have a
strong relationship with obesity, and more significantly, diabetes mellitus. Generally, this
is a consequence of the increase in insulin resistance, which is the net outcome of the
upwardly expressed signalling and immune processes and downwardly expressed
metabolic processes in the adipocytokine pathways. It is important to note that these

77

changes reflect cellular responses and have been observed effecting transcription activity
in the mammary tissue of female offspring via microarray profiling.
Although these changes were represented in the adipocytokine pathway, this is
not the only pathway involved. These changes in the adipocytokine pathway are only an
indication of statistical/bioinformatic programming taken place. Furthermore, the changes
in the adipocytokine pathway may be interpreted from different persectives. For example,
the changes seen per this analysis may comprise some portion of a larger system-wide
regulatory change, or there may have been changes in cellularity that express this
particular pathway. These potential changes in cellularity may reflect an imbalance
cellularity of parenchyma and adipose tissues in the mammary gland.
Overall, inflammatory processes were statistically up-regulated, and metabolic
processes were statistically down-regulated in the mammary gland. As shown earlier,
some immune components are significantly upstream and effect many downstream
transcript changes. It was observed that these changes in inflammatory processes were
maintained in ex-fat period until 10 wks and may reflect a possible permanent immune
dysregulation. The increased pup weight for ex-fat diets is likely due to increased
adipogenesis because of the nature of fatty diet. It is important to note that the mammary
glands themselves were not weighed. However, it is likely they experienced a weight
defect in accordance with body weight trajectory.
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Table 7. Processes and cancer implications for up-regulated genes of Adipocytokine
pathway
Up-regulated
Genes
Name

Biological
Process

Protein kinase C
theta (PKC)

signal
transduction

Protein kinase B
(AKT-1)

signal
transduction

Suppressor of
cytokine
signaling 3
(SOCS 3)

cytokineinducible
negative
regulators of
cytokine
signaling

Janus kinase 1
(JAK1)

Signal
transduction

Information
• Members of the PKC family are divided into three groups
based on their molecular structures and activating
mechanisms: 1) Conventional PKC (alpha, beta, and
gamma) requiring calcium, phosphatidylserine (PS), and
diacylglycerol (DG) for activation; 2) novel PKC (sigma,
epsilon, eta, and theta) activated independent of calcium;
and 3) Atypical PKC (zeta and lamda), which are
independent of both calcium and DG. High-level expression
of PKC-theta was found in skeletal muscle, lung, T cells,
and brain, and minimal expression in cardiac muscle,
placenta, and liver. PKC theta is a autophosphorylated
protein kinase.
• Mice lacking Akt1 display a 25% reduction in body mass,
indicating that Akt1 is critical for transmitting growth
promoting signals, most likel via the igf1 receptor. Mice
lacking atk1 are also resistant to cancer: they experience
considerable delay in tumor growth initiated by the large T
antigen or the Neu oncogene.
• inactivates components of the apoptotic machinery.
• Mammary carcinoma: Expression of activated Akt1 in
MMTV-c-ErbB2 mice accelerates tumourigenesis with a
reduced requirement for signalling through the EGFR
family, as well as a reduced requirement for a subset of
downstream signaling molecules with a metabolic shift in
the tumours from bitransgenic mice. (Young, Nolte et al.
2008)
• The expression of this gene is induced by various
cytokines, including IL6, IL10, and interferon (IFN)gamma. The protein encoded by this gene can bind to JAK2
kinase, and inhibit the activity of JAK2 kinase. Studies of
the mouse counterpart of this gene suggested the roles of
this gene in the negative regulation of fetal liver
hematopoiesis, and placental development.
• Elevated expression of SOCS genes is a specific lesion of
breast-cancer cells that may confer resistance to
proinflammatory cytokines and trophic factors, by shutting
down STAT1/STAT5 signaling that mediate essential
functions in the mammary gland. (Evans, Yu et al. 2006)
• upstream effector of downstream transcript modulation
(immune processes)
• Signaling of type 1 and 2 cytokines (IL-2, IL-4, gp130,
CNTF-R, NNT-1R, Leptin-R, IFN-alpha,beta,gamma
interferon’s, IL-10)
• In breast cancer cells, Jak1 not only stimulates
conventional prolactin signaling via proteins such as Stat5,
but also that Jak1 recruited new signals, especially Stat3
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Small
heterodimer
partner 2 (SHP2)

member of the
nuclear receptor
family of
intracellular
transcription
factors

Neuropeptide Y
2 (NPY-2)

peptide
neurotransmitter
found in the
brain and
autonomic
nervous system
upstream NF-κB
signal
transduction
cascade

IKappa B
Kinase gamma
(IKK-gamma)

Tumor necrosis
factor beta
(lymphotoxin
beta) (TNF-b)

Immune
response
(cytokine)

peroxisome
proliferatoractivated
receptors betadelta (PPAR-

nuclear hormone
receptors that
bind peroxisome
proliferators and
control the size

and ERK. Stat3 and ERK typically are considered tumorpromoting, so inhibitors of Jak1 may become useful in
breast cancer treatment.
• Results that may provide the basis for identifying another
mechanism of breast tumorigenesis via the JAK [?]/STAT
pathway in hypoxia.(Lee, Joung et al. 2006)
• SHP-2, a cytoplasmic SH2 domain containing protein
tyrosine phosphatase, is involved in the signaling pathways
of a variety of growth factors and cytokines. Recent studies
have clearly demonstrated that this phosphatase plays an
important role in transducing signal relay from the cell
surface to the nucleus, and is a critical intracellular
regulator in mediating cell proliferation and differentiation
(Qu 2000)
• Given SHP2's positive role in cell growth, transformation
and stem cell survival, the positive relationship of its
overexpression to lymph node metastasis, nuclear
accumulation of hormone receptors and higher tumour
grade suggests that SHP2 promotes breast oncogenesis
(Zhou, Coad et al. 2008)
• Feeds into MARK signaling pathway
• Effects Downstream transcription of epidermal growth
factor receptor (EGF-R) => Thus, we provide biological
evidence here that protein-tyrosine phosphatase SHP-2 acts
to enhance information flow from the EGF-R in mouse
growth and development (Qu, Yu et al. 1999)
HUGE RELATIONSHIP TO BREAST CANCER
• Decrease in food intake, increase in adipogenesis

• Regulatory subunit of IKK complex, which activates NFKappaB. IKKbeta (and IKKgamma) are essential for rapid
NF-kappaB activation by proinflammatory signaling
cascades, such as those triggered by tumor necrosis factor
alpha (TNFalpha) or lipopolysaccharide (LPS) (Hacker and
Karin 2006)
• IKK/NF kappa B system is generally overexpressed in
breast cancer cells and there is heterogeneity in expression
levels of individual members between different cell lines
• TNF-beta is involved in the regulation of various
biological processes including cell proliferation,
differentiation, apoptosis, lipid metabolism, coagulation,
and neurotransmission. TNF-beta is secreted as a soluble
polypeptide, but can form heterotrimers with lymphotoxinbeta, which effectively anchors the TNF-beta to the cell
surface. TNF-beta is cytotoxic to a wide range of tumor
cells.
• differentiation, lipid accumulation, directional sensing,
polarization, and migration in keratinocytes
• After fertilisation, PPAR-gamma and PPAR-beta/delta are
essential regulators of placentation and the subsequent
development of key metabolic tissues such as skeletal
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bd)

Glucose
Transporter 2
(GLUT-2)

and number of
peroxisomes
produced by
cells
carrier protein
and gene which
is involved in
passive glucose
transport

muscle and adipose cells (Rees, McNeil et al. 2008)
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Table 8. Processes and cancer implications for down-regulated genes of
Adipocytokine pathway
Down-regulated
Genes
Name
Insulin receptor
substrate (IRS)
Phosphoenolpyruvat
e carboxykinase
(PEPCK)
Adiponectin
receptor 2 (ADIPOR(2))

Biological
Process
elicits insulin’s
actions
Gluconeogensis
receptor for
adiponectin

AMP-activated
protein kinase
(AMPK)

• Both of the receptors activate AMPK and PPAR
alpha metabolic pathways leading to an increase in
fatty acid oxidation, glucose uptake and a decreased
rate of gluconeogenesis, thus enhancing insulin
sensitivity. Moreover effects of adiponectin mimic
many metabolic actions of insulin such as
augmenting blood flow and glucose disposal in NOdependent manner. The precise mechanism of
regulation of plasma adiponectin level is unknown.
Recently the mechanism of transcriptional activation
of adiponectin gene via PPAR gamma was
described. Its level seems to be decreased by
TNFalfa and beta-adrenergic agonists (Szopa,
Malczewska-Malec et al. 2004)
• Obesity decreased expression levels of
AdipoR1/R2, thereby reducing adiponectin
sensitivity, which finally leads to insulin resistance,
the so-called "vicious cycle." (Kadowaki and
Yamauchi 2005)
• Recently, low adiponectin levels are significantly
associated with an increased breast cancer risk
(Takahata, Miyoshi et al. 2007)
• The net effect of AMPK activation is stimulation of
hepatic fatty acid oxidation and ketogenesis,
inhibition of cholesterol synthesis, lipogenesis, and
triglyceride synthesis, inhibition of adipocyte
lipolysis and lipogenesis, stimulation of skeletal
muscle fatty acid oxidation and muscle glucose
uptake, and modulation of insulin secretion by
pancreatic beta-cells.
• key regulator of mitochondrial fat oxidation
• Taken together with previous work demonstrating
that Acc2(-/-) mice have a normal lifespan, these
data suggest that Acc2 inhibition is a viable
therapeutic option for the treatment of obesity and
type 2 diabetes (Choi, Savage et al. 2007)

Acetyl-CoA
carboxylase 2
(ACC-2)

GLUT 1,4,5

Information

carrier protein and
gene which is
involved in
passive glucose
transport
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CPT-1, 2

PGC-1alpha

PPCKC
NPY-1R

RXRG

IRS-4

• transport of long chain fatty acids across the
membrane by binding them to carnitine.
• Genes for fatty acid oxidation
(Sampath, Miyazaki et al. 2007)
• regulates the genes involved in energy metabolism
• The protection from obesity involves elevated
oxygen consumption/energy expenditure and
increased fatty acid oxidation in adipose tissue with
concurrent increased mitochondria genesis, upregulation of PGC-1alpha and UCP-2 [?], and downregulation of perilipin [?].
(Bansode, Huang et al. 2008)
• main control point for the regulation of
gluconeogenesis
• Y1-R-/- mice showed a moderate obesity and mild
hyperinsulinemia without hyperphagia. Although
there was some variation between males and
females, typical characteristics of Y1-R-/- mice
include: greater body weight (females more than
males), an increase in the weight of white adipose
tissue (WAT) (approximately 4-fold in females), an
elevated basal level of plasma insulin (approximately
2-fold), impaired insulin secretion in response to
glucose administration, and a significant changes in
mitochondrial uncoupling protein (UCP) gene
expression (up-regulation of UCP1 in brown adipose
tissue and down-regulation of UCP2 in
WAT).(Kushi, Sasai et al. 1998)
• involved in mediating the antiproliferative effects
of retinoic acid (RA).
• Retinoid X receptor gamma-deficient mice have
increased skeletal muscle lipoprotein lipase activity
and less weight gain when fed a high-fat diet.
• Protein phosphatase 4 interacts with and downregulates insulin receptor substrate 4 following
tumor necrosis factor-alpha
stimulation.(Mihindukulasuriya, Zhou et al. 2004)
• Acts as an interface between multiple growth factor
receptors possessing tyrosine kinase activity, such as
insulin receptor, IGF1R and FGFR1, and a complex
network of intracellular molecules containing SH2
domains.
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Our studies aim to identify new biomarker leads for altered developmental (fetal)
programming that correlate with early susceptibility to breast tumors. Such biomarker
leads may translate into molecular diagnostics for pre-malignant foci in human patients.
Comparative bioinformatics can reveal how closely the murine data reflects the human
response. These scenarios can be enhanced in the applications of prior knowledge of
established biomarkers for breast cancer (eg, ER-alpha, PrgR, EgfR, Her2-Neu, Cox2)
drawn from national databases, statistical reductions in the high-dimension data from
cellular microgenomics profiles, and the generation of new hypotheses regarding how
developmental programming of large genetic regulatory networks in specific precursor
target cell subpopulations might initiate and propagate changes in cell states leading to
breast cancer.
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6. SUMMARY AND CONCLUSIONS
In general, this study was performed as an exploratory study with gestationallactational exposure of Harlan mice to high-fat diets switched at 6-weeks postnatal. The
results can be summarized as follows. First, maternal high-fat diet altered growth
trajectories and gene expression in the mammary gland at 10 weeks. Second, flaxseed oil
diet (high in omega-3) had a lasting effect on body weight compared to a diet with corn
oil (high in omega-6). Third, the genomic response signatures based on a comprehensive
microarray analysis suggested that the changes were associated with a decrease in
expression of energy metabolism pathways and a reciprocal increase in cytokine and
inflammatory signaling pathways. Fourth, the changes in gene expression may reflect
imbalance of cellularity of parenchymal and adipose tissue that may influence the risk of
breast cancer.
We may conclude from this analysis that prenatal and perinatal exposure to a
high-fat (24%) diet had a long-term effect on postnatal body weights versus the regular
low-fat (5%) diet and that the latent effect persisted longer when the high-fat diet was
provided by flaxseed oil versus corn oil. Computational analysis demonstrated a decrease
in expression of energy pathways with a reciprocal increase in cytokine and inflammatory
signaling pathways. Computational pathway analysis using GeneGo software showed
these changes were reflected in the adipocytokine pathway, where the protein kinase
cascade and immune response pathways displayed upward programming, and metabolic
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processes displayed downward programming. Janus kinase 1 (JAK-1) and carnitine Opalmitoyltransferase I (CPT-1) expression levels were particularly affected. Because of
these changes, we may conclude that maternal dietary fat exposure significantly
influenced gene expression associated with metabolic programming and signaling
networks in the mammary gland of female offspring. In addition, the adipocytokine
pathway may be a sensitive trigger to dietary changes and this may influence or enhance
activation of an immune response, a key event in cancer development. Together, these
data suggest that maternal intake of a high-fat diet may predispose their offspring to
breast cancer.
More specifically, due to experimental design, it may be stated that omega-3
PUFAs causally affect mouse adolescent obesity and immune and metabolic
reprogramming of the mammary gland. Potential clinical implications of a enriched
omega-3 diet are epigenetic risk factors for breast cancer via dysregulatory inflammatory
changes and for type 2 diabetes via insulin resistance stemming from adolescent obesity.
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